Rephonic
Artwork for Oncology On The Go

Oncology On The Go

CancerNetwork
Clinical Trials
Immunotherapy
Multiple Myeloma
Breast Cancer
CAR T-Cell Therapy
Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Cancer Care
Lymphoma
Cytokine Release Syndrome
Kidney Cancer
Oncology
Mental Health
Chemotherapy
Bispecific Antibodies
FDA
Non-Small Cell Lung Cancer
Glioblastoma
Liquid Biopsy

Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As th... more

PublishesWeeklyEpisodes245Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Oncology On The Go

Latest Episodes

Cancer is never convenient, and it never arrives when a patient is truly prepared, according to Daniel C. McFarland, DO, who began the most recent episode of Oncology On the Go with this sentiment. When individuals enter the high-stakes, highly coord... more

In a live X Spaces discussion hosted by CancerNetwork® in collaboration with the American Society for Transplantation and Cellular Therapy (ASTCT), Marc J. Braunstein, MD, PhD, and Sofia Zahid, MD, highlighted noteworthy presentations and abstracts i... more

In a conversation with CancerNetwork®, Nathan Goodyear, MD, spoke about the role that exercise and lifestyle intervention can play in the treatment of patients with cancer. He described how prescribed exercise may serve as a biologically intervention... more

In a recent interview with CancerNetwork®, Nicholas Hornstein, MD, PhD, an assistant professor at the Donald and Barbara Zucker School of Medicine of Hofstra University and Northwell Health, discussed emerging data and clinical shifts in the care of ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine
The Journal.
The Journal.The Wall Street Journal & Spotify Studios
OncLive® On Air
OncLive® On AirOncLive® On Air

Recent Guests

Nick Hornstein
GI Medical Oncologist
Northwell Health
Episode: S1 Ep216: How the Landscape of GI Oncology is Evolving | A 2026 ASCO Preview
Mitchell Horwitz
From Duke Cancer Institute, spoke about key developments in allogeneic cord blood transplantation and Omaduba Cell
Duke Cancer Institute
Episode: S1 Ep215: Navigating The Dynamic Landscape of Stem Cell Transplantation
Timothy Yap
Dr. Timothy Yap, University of Texas MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center
Episode: S1 Ep214: Are Zedoresertib and Lunresertib an Efficacious Combo Across Solid Tumors?
Zahra Mahmoudjafari
Clinical Pharmacy Manager, University of Kansas Health System
University of Kansas Health System
Episode: S1 Ep213: What Does the Future Hold for Immune Effector Cell Therapies?
Barry Paul
Physician/researcher from Atrium Health Levine Cancer Institute
Atrium Health Levine Cancer Institute
Episode: S1 Ep213: What Does the Future Hold for Immune Effector Cell Therapies?
Dr. Diane Simeone
Director at Moores Cancer Center, UC San Diego Health
Moores Cancer Center, University of California San Diego Health
Episode: S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
Hitomi Hosoya
Physician-scientist, hematologist
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Episode: S1 Ep211: Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
Shari Goldfarb
Oncologist at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: S1 Ep209: Rising Incidence, Trial Enrollment, and Other Key Breast Cancer Challenges
Kelly Irwin
Former president of the American Psychosocial Oncology Society (APOS)
APOS
Episode: S1 Ep208: Cancer and Suicide: Identifying Risk Factors and Providing Support

Hosts

Russ Conroy
Host of Oncology On The Go, frequently guiding interviews and synthesizing clinical relevance.
Arianna Pelosi
Co-host, facilitates episodes and provides clinical context.
Ruscon Roy
Host contributing expert perspectives and clinical discussion.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#156
Switzerland/Science
Apple Podcasts
#245
South Korea/Science

Talking Points

Recent interactions between the hosts and their guests.

S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
Q: Developmentally what do these findings with the KRAS inhibitor mean for the future landscape of PDAC development?
This breakthrough is a holy grail moment that validates pursuing KRAS-targeted therapies, supports down-staging strategies with early detection, and suggests combining KRAS inhibitors with other modalities could drive higher cure rates if applied earlier in the disease course.
S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
Q: What are the logistical obstacles or maybe what needs to be put in place for that to be able to happen for more patients to be genetically tested?
Key steps include increasing awareness of national guidelines like NCCN, advocating for germline testing and tumor sequencing, enabling multidisciplinary care, and expanding access so more patients can benefit from precision oncology approaches.
S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
Q: For a while, KRAS was considered notoriously undruggable, but this inhibitor does drug KRAS. What about this agent is able to do that?
The approach leverages an understanding of KRAS structure and uses a small molecule to remodel the surface, enabling targeting of a shallow pocket; this, along with advances in chemistries and degraders, allows a druggable interaction with KRAS.
S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
Q: Just to start off, these OOS adults have garnered a lot of attention from everyone across the oncology spectrum and even in the mainstream. What were these OOS findings and why are they so significant?
The discussion underscores how the results are compelling because they demonstrate a meaningful survival advantage in a disease with few effective options, suggesting KRAS-targeted approaches could broadly shift outcomes for metastatic pancreatic cancer beyond BRCA-mutant subgroups and traditional regimens.
S1 Ep211: Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
Q: What indicators or tests might help identify patients at risk or early onset of this GI CAR-T lymphomagenesis?
Possible approaches include pre- and post-manufacture sequencing to detect low-frequency mutations like SS2V3, monitoring for GI symptoms early after CAR-T infusion, and employing targeted GI tissue analyses when indicated by clinical signs.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology On The Go

What is Oncology On The Go about and what kind of topics does it cover?

This show features in-depth conversations with leading oncology clinicians, researchers, and thought leaders who discuss high-impact topics in cancer treatment, research updates, and the practical implications of new data. Episodes frequently center on immunotherapy, targeted therapies, cell therapies, and emerging biomarkers, often tying trial results and conference takeaways to real-world practice, patient care, and health-system implementation. A notable strength is the multidisciplinary lens—discussants span medical oncology, hematology, translational biology, and supportive care—making it useful for listeners who want clinically relevant insights, actionable takeaways, and context for evolving standards of care. The format often includ... more

Where can I find podcast stats for Oncology On The Go?

Rephonic provides a wide range of podcast stats for Oncology On The Go. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology On The Go and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology On The Go get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology On The Go, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology On The Go?

Rephonic provides comprehensive predictive audience data for Oncology On The Go, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology On The Go have?

To see how many followers or subscribers Oncology On The Go has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology On The Go?

These podcasts share a similar audience with Oncology On The Go:

1. ASCO Daily News
2. Two Onc Docs
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. The Journal.
5. OncLive® On Air

How many episodes of Oncology On The Go are there?

Oncology On The Go launched 6 years ago and published 245 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology On The Go?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology On The Go?

Rephonic pulls ratings and reviews for Oncology On The Go from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology On The Go?

Rephonic provides full transcripts for episodes of Oncology On The Go. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology On The Go?

Recent guests on Oncology On The Go include:

1. Nick Hornstein
2. Mitchell Horwitz
3. Timothy Yap
4. Zahra Mahmoudjafari
5. Barry Paul
6. Dr. Diane Simeone
7. Hitomi Hosoya
8. Shari Goldfarb

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days